PH receives 3 new Covid-19 clinical trial applications radyonatin.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from radyonatin.com Daily Mail and Mail on Sunday newspapers.
January 21, 2021 • 11:32 am CST (Precision Vaccinations)
South Korea-based EuBiologics announced the Korean Ministry of Food and Drug Safety approved a clinical trial of EuCOVAC-19 , a new COVID-19 vaccine candidate. The clinical trial is aimed at evaluating EuCOVAC-19’s safety and immunogenicity for healthy adults and will proceed with Phase 1 and Phase 2 studies sequentially.
EuCOVAC-19 is a recombinant vaccine based on surface antigen proteins from the COVID-19 virus, SARS-CoV-2. The vaccine s surface antigen proteins form neutralizing antibodies by stimulating immune cells. When the COVID-19 coronavirus breaks into the body, the antibodies kill the COVID-19 virus.
The Korean ministry stated that it had given clinical trial approval to seven COVID-19 vaccines, including EuCOVAC-19, and fifteen COVID-19 treatments, as of January 11, 2021.